Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
Clinical trial NCT05669261 · UNKNOWN
Trial details
- NCT number
- NCT05669261
- Sponsor
- American CryoStem Corporation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2023-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.